40.61 M
About Wuhan General Group (China), Inc.
Sector
CEO
Jeff Robinson
Headquarters
Cape Town
Website
Founded
1988
ISIN
US9825691051
FIGI
BBG000BDYK06
Wuhan General Group (China), Inc. is a nutraceutical biotechnology company, which engages in the development of alternative plant-based cannabinoids and psilocybin medical research that commercializes a range of cannabidiol and mushrooms-based products under the Dr. AnnaRx, Medspresso and Handcrafted Delights brands. The firm is also engages in research and development of indications for psilocybin new therapies that will help patients who suffer from mental illness, Alzheimer's and Parkinson's. The company was founded by Xu Jie and Jeff Robinson on July 19, 1988 and is headquartered in Cape Town, South Africa.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of WUHN is 0.000001 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Wuhan General Group (China), Inc. stocks are traded under the ticker WUHN.
WUHN stock is 0% volatile and has beta coefficient of −0.57. Check out the list of the most volatile stocks — is Wuhan General Group (China), Inc. there?
Yes, you can track Wuhan General Group (China), Inc. financials in yearly and quarterly reports right on TradingView.
No, WUHN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, WUHN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Wuhan General Group (China), Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Wuhan General Group (China), Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Wuhan General Group (China), Inc. stock shows the sell signal. See more of Wuhan General Group (China), Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.